http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019002448-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_617af29dc4cd94fcc0c4412a69786677 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9459bf6979a2029937f89e65d2403269 |
publicationDate | 2019-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2019002448-A1 |
titleOfInvention | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof |
abstract | The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (I) or (II), or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula A, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020102292-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858347-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008309-B2 |
priorityDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3067.